Multiple imputation methodology is reflective of secukinumab efficacy in real clinical practice: Data from the FIXTURE and ERASURE studies in moderate to severe plaque psoriasis

被引：0
|
作者：
Langley, Richard [1 ]
Reich, Kristian [2 ,3 ]
Papavassilis, Charms [4 ]
Fox, Todd [4 ]
Gong, Yankun [5 ]
Guettner, Achim [4 ]
机构：
[1] Dalhousie Univ, Halifax, NS, Canada
[2] Dermatologikum Hamburg, Hamburg, Germany
[3] SCIderm Res Inst, Hamburg, Germany
[4] Novartis Pharma AG, Basel, Switzerland
[5] Beijing Novartis Pharma Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2015年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P047
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [21] Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT study
    Koerber, A.
    Thaci, D.
    von Kiedrowski, R.
    Bachhuber, T.
    Melzer, N.
    Kasparek, T.
    Kraehn-Senftleben, G.
    Amon, U.
    Augustin, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : 411 - 419
  • [22] Efficacy and Safety of Secukinumab in Elderly Subjects with Moderate to Severe Plaque Psoriasis: A Pooled Analysis of Phase III Studies
    Andreas Körber
    Charis Papavassilis
    Vaishali Bhosekar
    Maximilian Reinhardt
    Drugs & Aging, 2018, 35 : 135 - 144
  • [23] Efficacy and safety of secukinumab (IL-17A inhibitor) in treating moderate to severe plaque psoriasis in real-world clinical practice: A Canadian multicenter retrospective study
    Georgakopoulos, Jorge-Ryan
    Ighani, Arvin
    Yeung, Jensen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB114 - AB114
  • [24] Secukinumab efficacy in subjects with moderate to severe plaque psoriasis: Pooled subgroup analyses by patient age of 4 phase 3 clinical studies
    Warren, Richard
    Guettner, Achim
    Morita, Akimichi
    Gisondi, Paolo
    Cooper, Simon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB186 - AB186
  • [25] Effectiveness and security of secukinumab in patients with moderate to severe psoriasis in real clinical practice in a tertiary referral hospital
    Arteaga-Henriquez, Maria
    Lukoviek-Araya, Vania
    Maria Ramirez-Conchas, Jose
    Markthaler, Marcella
    Perez-Robayna, Nuria
    de-Andres-del-Rosario, Ana
    Guimera-Martin-Neda, Francisco
    Garcia-Bustinduy, Marta
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB51 - AB51
  • [26] Efficacy and safety of secukinumab in Chinese patients with moderate-to-severe plaque psoriasis: a real-life cohort study
    Zhao, Yan
    Cai, Lin
    Liu, Xiao-Yang
    Zhang, Heng
    Zhang, Jian-Zhong
    CHINESE MEDICAL JOURNAL, 2021, 134 (11) : 1324 - 1328
  • [27] Secukinumab efficacy and safety in subjects with moderate to severe plaque psoriasis: Results from the Judging the efficacy of secUkinumab in patients with psoriasis using autoiNjector: a Clinical Trial evalUating treatment REsults trial (JUNCTURE)
    Blauvelt, Andrew
    Gottlieb, Alice
    Prinz, Jorg
    Pathan, Rashidkhan
    Cooper, Simon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB185 - AB185
  • [28] Secukinumab Treatment of moderate to severe Plaque Psoriasis in the clinical Routine Care: Baseline Data from the PROSPECT Study on Psoriasis Pre-treatment
    von Kiedrowski, R.
    Korber, A.
    Kraehn-Senftleben, G.
    Sticherling, M.
    Lange, L.
    Bachhuber, T.
    Kasparek, T. R.
    Augustin, M.
    Thaci, D.
    Amon, U.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 138 - 138
  • [29] Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry
    Papp, Kim A.
    Gooderham, Melinda
    Lynde, Charles
    Brassard, Danielle
    Al-Mohammedi, Faisal
    Prajapati, Vimal H.
    Delorme, Isabelle
    Albrecht, Lorne
    Haydey, Richard
    Alam, Maryam Shayesteh
    Beecker, Jennifer
    Siddha, Sanjay
    Maguin, Marie
    Farag, Mahmoud S.
    Vieira, Antonio
    Rihakova, Lenka
    Langley, Richard G.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (07)
  • [30] Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: Subanalysis from ERASURE, a randomized, placebo-controlled, phase 3 study
    Ohtsuki, Mamitaro
    Morita, Akimichi
    Abe, Masatoshi
    Takahashi, Hidetoshi
    Seko, Noriko
    Karpov, Alexander
    Shima, Tomohiro
    Papavassilis, Charis
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2014, 41 (12): : 1039 - 1046
12345